Results 201 to 210 of about 636,610 (341)

Hα‐derived Star Formation Rates for Threez≃0.75 EDisCS Galaxy Clusters [PDF]

, 2005
Rose Finn, Dennis Zaritsky, Donald W. McCarthy, Bianca M. Poggianti, Gregory Rudnick, Claire Halliday, B. Milvang‐Jensen, R. Pelló, Luc Simard   +8 more
openalex   +1 more source

The Rate of Star Formation. II. The Rate of Formation of Stars of Different Mass.

The Astrophysical Journal, 1963
openaire   +3 more sources

Predicting organoid morphology through a phase field model: Insights into cell division and lumenal pressure. [PDF]

PLoS Comput Biol
Tanida S, Fuji K, Lu L, Guyomar T, Lee BH, Honigmann A, Grapin-Botton A, Riveline D, Hiraiwa T, Nonomura M, Sano M.   +10 more
europepmc   +1 more source

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

Molecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner, Markus Eckstein, Christoph Mark, Matthias W. Beckmann, Arndt Hartmann, Pamela L. Strissel, Reiner Strick   +6 more
wiley   +1 more source

Estimating Star Formation Rates from Infrared and Radio Luminosities: The Origin of the Radio‐Infrared Correlation

, 2003
Eric F. Bell
openalex   +1 more source

Specific Star Formation Rates to Redshift 1.5 [PDF]

, 2005
A. Bauer, Niv Drory, Gary J. Hill, Georg Feulner   +3 more
openalex   +1 more source

Pasteurization-Triggered Heat-Resistant Enhancement of Packaging Films Derived from a Star-Shape Toughened Polylactide Stereocomplex. [PDF]

ACS Omega
Buchatip S, Supmak W, Sangroniz L, Opaprakasit M, Petchsuk A, Opaprakasit P, Müller AJ.   +6 more
europepmc   +1 more source

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

Flux equipartition in astrophysical plasma turbulence. [PDF]

Sci Adv
Marino R, Xie JH.
europepmc   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

Molecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef, Hana Barhom, Sumit Chatterji, Netta Hecht, Oran Warhaftig, Iris Kamer, Oranit Zadok, Jair Bar, Limor Broday, Amir Onn, Michael Peled   +10 more
wiley   +1 more source